14bn towards the project, which could create more than 13,000 jobs.
The article from the BBC discusses the ongoing debate over the use of puberty blockers for transgender youth in the UK. It highlights the recent decision by NHS England to halt the routine prescription of puberty blockers to children and young people, following a review that found insufficient evidence on their safety and effectiveness. This decision has sparked a range of reactions: some medical professionals and activists argue that this move could harm transgender youth by denying them necessary care, while others, including some clinicians and parents, support the decision, citing concerns over long-term effects and the need for more research. The article also touches on the broader implications for transgender healthcare, mentioning the closure of the Tavistock clinic's Gender Identity Development Service (GIDS) and the establishment of new regional hubs to provide more comprehensive care. The debate encapsulates issues of medical ethics, the rights of transgender youth, and the balance between caution and access to treatment.
Travel & Leisure
